Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the company's own shares executed on August 26, 2025, and announced on August 27, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Shares Purchased | 2,975,063 |
| Purchase Date | August 26, 2025 |
| Highest Price Paid | 363.30 pence |
| Lowest Price Paid | 355.60 pence |
| Volume Weighted Average Price | 359.1984 pence |
| Post-Transaction Registered Capital | 8,966,351,142 ordinary shares |
| Treasury Shares Held | 3,880,205 |
| Voting Shares Outstanding | 8,962,470,937 |
Material Changes
This transaction represents the second tranche of a share buyback programme announced on July 31, 2025. The purchase resulted in the cancellation of the acquired shares, reducing the total number of shares with voting rights.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific capital allocation event.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the full buyback programme announced on July 31, 2025.
- Confirm the remaining authorization limit for the current share buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular execution data.
- Check subsequent filings for the impact of this cancellation on earnings per share (EPS) calculations.